vs
帕森斯公司（PSN）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
帕森斯公司的季度营收约是瑞思迈的1.0倍（$1.5B vs $1.4B），瑞思迈净利率更高（27.6% vs 3.5%，领先24.0%），瑞思迈同比增速更快（11.0% vs 3.0%），过去两年瑞思迈的营收复合增速更高（7.8% vs -5.5%）
帕森斯公司是一家总部位于美国弗吉尼亚州尚蒂利的跨国企业，1944年成立，核心业务覆盖国防、情报、基础设施工程领域，深耕技术研发，在全球30多个国家为政府及私营部门客户提供专业解决方案。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
PSN vs RMD — 直观对比
营收规模更大
PSN
是对方的1.0倍
$1.4B
营收增速更快
RMD
高出8.0%
3.0%
净利率更高
RMD
高出24.0%
3.5%
两年增速更快
RMD
近两年复合增速
-5.5%
损益表 — Q1 FY2026 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.4B |
| 净利润 | $52.9M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 6.4% | 34.6% |
| 净利率 | 3.5% | 27.6% |
| 营收同比 | 3.0% | 11.0% |
| 净利润同比 | -20.1% | 13.9% |
| 每股收益（稀释后） | $0.49 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PSNRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | $1.5B | $1.4B | ||
| Q4 25 | $1.6B | $1.4B | ||
| Q3 25 | $1.6B | $1.3B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.8B | $1.2B |
净利润PSNRMD
| Q2 26 | — | $392.6M | ||
| Q1 26 | $52.9M | $398.7M | ||
| Q4 25 | $55.6M | $392.6M | ||
| Q3 25 | $64.1M | $348.5M | ||
| Q2 25 | $55.2M | $379.7M | ||
| Q1 25 | $66.2M | $365.0M | ||
| Q4 24 | $201.3M | $344.6M | ||
| Q3 24 | $72.0M | $311.4M |
毛利率PSNRMD
| Q2 26 | — | 61.8% | ||
| Q1 26 | — | 62.2% | ||
| Q4 25 | 23.0% | 61.8% | ||
| Q3 25 | 22.2% | 61.5% | ||
| Q2 25 | 22.0% | 60.8% | ||
| Q1 25 | 22.8% | 59.3% | ||
| Q4 24 | 21.3% | 58.6% | ||
| Q3 24 | 19.9% | 58.6% |
营业利润率PSNRMD
| Q2 26 | — | 34.6% | ||
| Q1 26 | 6.4% | 34.9% | ||
| Q4 25 | 6.6% | 34.6% | ||
| Q3 25 | 6.7% | 33.4% | ||
| Q2 25 | 6.0% | 33.7% | ||
| Q1 25 | 7.0% | 33.0% | ||
| Q4 24 | 5.8% | 32.5% | ||
| Q3 24 | 6.4% | 31.6% |
净利率PSNRMD
| Q2 26 | — | 27.6% | ||
| Q1 26 | 3.5% | 27.9% | ||
| Q4 25 | 3.5% | 27.6% | ||
| Q3 25 | 4.0% | 26.1% | ||
| Q2 25 | 3.5% | 28.2% | ||
| Q1 25 | 4.3% | 28.3% | ||
| Q4 24 | 11.6% | 26.9% | ||
| Q3 24 | 4.0% | 25.4% |
每股收益（稀释后）PSNRMD
| Q2 26 | — | $2.68 | ||
| Q1 26 | $0.49 | $2.74 | ||
| Q4 25 | $0.51 | $2.68 | ||
| Q3 25 | $0.59 | $2.37 | ||
| Q2 25 | $0.50 | $2.58 | ||
| Q1 25 | $0.60 | $2.48 | ||
| Q4 24 | $1.85 | $2.34 | ||
| Q3 24 | $0.65 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | $1.5B | $663.8M |
| 股东权益账面价值 | $2.8B | $6.3B |
| 总资产 | $6.0B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.55× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资PSNRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.7B | ||
| Q4 25 | $466.4M | $1.4B | ||
| Q3 25 | $422.6M | $1.4B | ||
| Q2 25 | $411.3M | $1.2B | ||
| Q1 25 | $269.7M | $932.7M | ||
| Q4 24 | $453.5M | $521.9M | ||
| Q3 24 | $558.8M | $426.4M |
总债务PSNRMD
| Q2 26 | — | $663.8M | ||
| Q1 26 | $1.5B | $664.1M | ||
| Q4 25 | $1.2B | $403.9M | ||
| Q3 25 | $1.2B | $408.7M | ||
| Q2 25 | $1.2B | $658.4M | ||
| Q1 25 | $785.2M | $663.1M | ||
| Q4 24 | $784.1M | $662.9M | ||
| Q3 24 | $1.1B | $667.6M |
股东权益PSNRMD
| Q2 26 | — | $6.3B | ||
| Q1 26 | $2.8B | $6.5B | ||
| Q4 25 | $2.6B | $6.3B | ||
| Q3 25 | $2.6B | $6.1B | ||
| Q2 25 | $2.5B | $6.0B | ||
| Q1 25 | $2.5B | $5.5B | ||
| Q4 24 | $2.4B | $5.3B | ||
| Q3 24 | $2.3B | $5.2B |
总资产PSNRMD
| Q2 26 | — | $8.5B | ||
| Q1 26 | $6.0B | $8.8B | ||
| Q4 25 | $5.8B | $8.5B | ||
| Q3 25 | $5.7B | $8.3B | ||
| Q2 25 | $5.7B | $8.2B | ||
| Q1 25 | $5.4B | $7.6B | ||
| Q4 24 | $5.5B | $7.1B | ||
| Q3 24 | $5.4B | $7.2B |
负债/权益比PSNRMD
| Q2 26 | — | 0.11× | ||
| Q1 26 | 0.55× | 0.10× | ||
| Q4 25 | 0.47× | 0.06× | ||
| Q3 25 | 0.48× | 0.07× | ||
| Q2 25 | 0.49× | 0.11× | ||
| Q1 25 | 0.32× | 0.12× | ||
| Q4 24 | 0.32× | 0.13× | ||
| Q3 24 | 0.49× | 0.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
